Cellectis S.A. Files December 2025 6-K Report
Ticker: CLLS · Form: 6-K · Filed: Dec 8, 2025 · CIK: 1627281
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
Cellectis filed its routine Dec 2025 6-K, no new info.
AI Summary
Cellectis S.A. filed a Form 6-K on December 8, 2025, reporting for the month of December 2025. The company, a biopharmaceutical firm based in Paris, France, is a foreign private issuer and files its annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Cellectis S.A. is fulfilling its regular reporting obligations as a foreign private issuer with the SEC. It does not provide new material information for investors at this time.
Risk Assessment
Risk Level: low — This is a routine filing that does not contain new material information or significant financial updates.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- 001-36891 (company) — SEC File Number
- 20251208 (date) — Filing Date
- Paris, France (location) — Company Headquarters
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Who is the filer?
The filer is Cellectis S.A.
When was this report filed?
The report was filed on December 8, 2025.
Does Cellectis S.A. file annual reports under Form 20-F or 40-F?
Cellectis S.A. indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address of Cellectis S.A.?
The principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2025-12-08 06:00:11
Filing Documents
- f6k_120725.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 8KB
- 0001171843-25-007781.txt ( ) — 15KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: December 8, 2025 /s/ Andr Choulika Andr Choulika Chief Executive Officer